Early Post-Market Surveillance of Bimodal Neuromodulation for Tinnitus

Clinicians fitting or referring patients for Lenire should review the emerging real-world adverse event and efficacy data from MAUDE to counsel patients accurately, though practice-changing conclusions require full review of the published findings.